FDAs 2026 Epitalon Assessment The assessment concerned US pharmacy compounding and remained a proposal ahead of the advisory meeting
BPC-157 and other peptides referenced here are not approved by the MHRA, FDA, or any other regulatory body for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease or condition
A lower Firmicutes/Bacteroidetes ratio (142), reduced counts of Lactobacillaceae (143), and altered abundance of several genera have been reported (144) including Eggerthella , Klebsiella , Flavonifractor , Lachnospiraceae (145, 146), Prevotella , Eubacterium, and Rhodococcus were significantly enriched, whereas Pseudobutyrivibrio and Dialister were decreased in SLE patients (147)
BPC-157 is a short chain of amino acids derived from protective gastric proteins